Response to telitacicept in systemic lupus erythematosus patients: a real‐world, single‐center observational study in China

International Journal of DermatologyEarly View Letter to the Editor Response to telitacicept in systemic lupus erythematosus patients: a real-world, single-center observational study in China Yidan Liu, Yidan Liu Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China These authors contributed equally to this paper.Search for more papers by this authorYanshan Zhu, Yanshan Zhu Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China These authors contributed equally to this paper.Search for more papers by this authorYuwen Su, Yuwen Su Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorMin Deng, Min Deng Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorXiao Zhou, Xiao Zhou Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorQiao Wang, Qiao Wang Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorSiying Li, Siying Li Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorPeng Zhang, Corresponding Author Peng Zhang [email protected] orcid.org/0000-0002-2912-5347 Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorRuifang Wu, Corresponding Author Ruifang Wu [email protected] orcid.org/0000-0001-9923-949X Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this author Yidan Liu, Yidan Liu Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China These authors contributed equally to this paper.Search for more papers by this authorYanshan Zhu, Yanshan Zhu Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China These authors contributed equally to this paper.Search for more papers by this authorYuwen Su, Yuwen Su Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorMin Deng, Min Deng Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorXiao Zhou, Xiao Zhou Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorQiao Wang, Qiao Wang Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorSiying Li, Siying Li Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorPeng Zhang, Corresponding Author Peng Zhang [email protected] orcid.org/0000-0002-2912-5347 Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorRuifang Wu, Corresponding Author Ruifang Wu [email protected] orcid.org/0000-0001-9923-949X Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaSearch for more papers by this author First published: 12 June 2024 https://doi.org/10.1111/ijd.17321 Conflict of interest: None. Funding source: This work was supported by grants from the National Natural Science Foundation of China (grant number 82173427), the Hunan Province Science Foundation for Young Scientists of China (grant number 2022JJ40716), and the Natural Science Foundation of Hunan Province (grant number 2024JJ9196). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021; 17(9): 515–532. 10.1038/s41584-021-00668-1 PubMedWeb of Science®Google Scholar 2Ma K, Du W, Wang X, Yuan S, Cai X, Liu D, et al. Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci. 2019; 20(23): 6021. 10.3390/ijms20236021 CASPubMedWeb of Science®Google Scholar 3Dhillon S. Telitacicept: first approval. Drugs. 2021; 81(14): 1671–1675. 10.1007/s40265-021-01591-1 CASPubMedWeb of Science®Google Scholar 4Golder V, Kandane-Rathnayake R, Huq M, Nim HT, Louthrenoo W, Luo SF, et al. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. Lancet Rheumatol. 2019; 1(2): e95–e102. 10.1016/S2665-9913(19)30037-2 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation